참고문헌
- Cho JY, Suh KS, Lee HW, Cho EH, Yang SH, Cho YB, et al. Hypoattenuation in unenhanced CT reflects histological graft dysfunction and predicts 1-year mortality after living donor liver transplantation. Liver Transpl 2006;12:1403-11. https://doi.org/10.1002/lt.20772
- Chang TH, Hakamada K, Toyoki Y, Tsuchida S, Sasaki M. Expression of MRP2 and MRP3 during liver regeneration after 90% partial hepatectomy in rats. Transplantation 2004;77:22-7. https://doi.org/10.1097/01.TP.0000089234.93366.6D
- Hoekstra H, Tian Y, Jochum W, Stieger B, Graf R, Porte RJ, et al. Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression. Transplantation 2008;85:1159-66. https://doi.org/10.1097/TP.0b013e31816b2465
- Keppler D, Konig J. Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis 2000;20:265-72. https://doi.org/10.1055/s-2000-9391
- Kim PK, Chen J, Andrejko KM, Deutschman CS. Intraabdominal sepsis downregulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats. Shock 2000;14:176-81. https://doi.org/10.1097/00024382-200014020-00017
- Vos TA, Hooiveld GJ, Koning H, Childs S, Meijer DK, Moshage H, et al. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 1998;28:1637-44. https://doi.org/10.1002/hep.510280625
- Zollner G, Fickert P, Zenz R, Fuchsbichler A, Stumptner C, Kenner L, et al. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 2001;33:633-46. https://doi.org/10.1053/jhep.2001.22646
- Ros JE, Libbrecht L, Geuken M, Jansen PL, Roskams TA. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J Pathol 2003;200:553-60. https://doi.org/10.1002/path.1379
- Kojima H, Nies AT, Konig J, Hagmann W, Spring H, Uemura M, et al. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. J Hepatol 2003; 39:693-702. https://doi.org/10.1016/S0168-8278(03)00410-0
- Kullak-Ublick GA, Baretton GB, Oswald M, Renner EL, Paumgartner G, Beuers U. Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis. Hepatol Res 2002;23:78-82. https://doi.org/10.1016/S1386-6346(01)00159-0
- Alvarez L, Jara P, Sanchez-Sabate E, Hierro L, Larrauri J, Diaz MC, et al. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1. Hum Mol Genet 2004;13:2451-60. https://doi.org/10.1093/hmg/ddh261
- Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13. https://doi.org/10.1097/01.sla.0000133083.54934.ae
- Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997;113:255-64. https://doi.org/10.1016/S0016-5085(97)70103-3
- Paulusma CC, Kothe MJ, Bakker CT, Bosma PJ, van Bokhoven I, van Marle J, et al. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology 2000;31:684-93. https://doi.org/10.1002/hep.510310319
- Chai J, Cai SY, Liu X, Lian W, Chen S, Zhang L, et al. Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis. J Hepatol 2015;63:1440-8. https://doi.org/10.1016/j.jhep.2015.07.016
- Kudo A, Ban D, Aihara A, Irie T, Ochiai T, Nakamura N, et al. Decreased Mrp2 transport in severe macrovesicular fatty liver grafts. J Surg Res 2012;178:915-21. https://doi.org/10.1016/j.jss.2012.04.057
- Lee HW, Suh KS, Shin WY, Cho EH, Yi NJ, Lee JM, et al. Classification and prognosis of intrahepatic biliary stricture after liver transplantation. Liver Transpl 2007;13:1736-42. https://doi.org/10.1002/lt.21201
- Foley DP, Fernandez LA, Leverson G, Anderson M, Mezrich J, Sollinger HW, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg 2011;253:817-25. https://doi.org/10.1097/SLA.0b013e3182104784
- Cursio R, Gugenheim J. Ischemia-reperfusion injury and ischemic-type biliary lesions following liver transplantation. J Transplant 2012;2012:164329.
- Park JB, Kwon CH, Choi GS, Chun JM, Jung GO, Kim SJ, et al. Prolonged cold ischemic time is a risk factor for biliary strictures in duct-to-duct biliary reconstruction in living donor liver transplantation. Transplantation 2008;86:1536-42. https://doi.org/10.1097/TP.0b013e31818b2316
- Chok KS, Chan SC, Cheung TT, Sharr WW, Chan AC, Lo CM, et al. Bile duct anastomotic stricture after adult-to-adult right lobe living donor liver transplantation. Liver Transpl 2011;17:47-52. https://doi.org/10.1002/lt.22188
- Farid WR, de Jonge J, Slieker JC, Zondervan PE, Thomeer MG, Metselaar HJ, et al. The importance of portal venous blood flow in ischemic-type biliary lesions after liver transplantation. Am J Transplant 2011;11:857-62. https://doi.org/10.1111/j.1600-6143.2011.03438.x
- Hoekstra H, Porte RJ, Tian Y, Jochum W, Stieger B, Moritz W, et al. Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+/- mice. Hepatology 2006;43:1022-31. https://doi.org/10.1002/hep.21169
- Sun P, Wang C, Liu Q, Meng Q, Zhang A, Huo X, et al. OATP and MRP2-mediated hepatic uptake and biliary excretion of eprosartan in rat and human. Pharmacol Rep 2014;66:311-9. https://doi.org/10.1016/j.pharep.2014.02.013
- Saito S, Obata A, Kashiwagi Y, Abe K, Murase K. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA. Invest Radiol 2013;48:548-53. https://doi.org/10.1097/RLI.0b013e3182856a06
- Bernhardt GA, Zollner G, Cerwenka H, Kornprat P, Fickert P, Bacher H, et al. Hepatobiliary transporter expression and post-operative jaundice in patients undergoing partial hepatectomy. Liver Int 2012;32:119-27. https://doi.org/10.1111/j.1478-3231.2011.02625.x
- Nishioka T, Hyogo H, Numata Y, Yamaguchi A, Kobuke T, Komichi D, et al. A nuclear receptor-mediated choleretic action of fibrates is associated with enhanced canalicular membrane fluidity and transporter activity mediating bile acid-independent bile secretion. J Atheroscler Thromb 2005;12:211-7. https://doi.org/10.5551/jat.12.211
- Stapelbroek JM, van Erpecum KJ, Klomp LW, Houwen RH. Liver disease associated with canalicular transport defects: current and future therapies. J Hepatol 2010;52:258-71. https://doi.org/10.1016/j.jhep.2009.11.012
- Kivisto KT, Niemi M. Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans. Pharm Res 2007;24:239-47. https://doi.org/10.1007/s11095-006-9159-2